Literature DB >> 29739122

Serum CEA and CA19-9 Levels are Associated with the Presence and Severity of Colorectal Neoplasia.

Hengyong Zhai, Junxing Huang, Chuanchun Yang, Yiwei Fu, Bin Yang.   

Abstract

BACKGROUND: High concentrations of carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) were found in the serum of patients with colon cancer. We performed the present work to investigate the association between elevated levels of serum biomarkers (CEA and CA19-9) and shortened survival in patients with colon cancer.
METHODS: We examined patients who underwent colonoscopies between 2001 and 2014 and measured and analyzed the serum CEA and CA19-9 levels of 362 participants.
RESULTS: Elevated CEA concentrations were found to be associated with advanced invasion, lymph node metastasis, and short survival. Elevated CA19-9 concentrations also were associated with lymph node metastasis and short survival.
CONCLUSIONS: Elevated serum CEA or CA19-9 levels were found to be associated with shortened survival.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29739122     DOI: 10.7754/Clin.Lab.2017.170914

Source DB:  PubMed          Journal:  Clin Lab        ISSN: 1433-6510            Impact factor:   1.138


  8 in total

1.  Nomogram model characterized by mutant genes and clinical indexes to identify high-risk patients with stage III/IV colorectal cancer.

Authors:  Kai Liu; Cui Wang; Jiefu Wang; Yang Zhan; Xin Yue; Dalu Kong
Journal:  J Gastrointest Oncol       Date:  2020-12

2.  Higher plasma concentration of TP53-induced glycolysis and apoptosis regulator is associated with a lower risk of colorectal cancer metastasis.

Authors:  Lin Lin; Yanjun Mi; Xun Li; Cuixin Peng; Zhaoshui Shangguan; Zhibin Li; Suhuan Liu
Journal:  Cancer Manag Res       Date:  2018-12-24       Impact factor: 3.989

3.  Combining Red Blood Cell Distribution Width (RDW-CV) and CEA Predict Poor Prognosis for Survival Outcomes in Colorectal Cancer.

Authors:  Yalun Li; Chengzhong Xing; Minjie Wei; Huizhe Wu; Xiaoyun Hu; Shanqiong Li; Guangwei Sun; Guangzhe Zhang; Bo Wu; Fangxiao Zhang; Zhuang Li
Journal:  J Cancer       Date:  2019-01-29       Impact factor: 4.207

Review 4.  Metastatic pancreatic cancer: Mechanisms and detection (Review).

Authors:  Xiangling Chen; Fangfang Liu; Qingping Xue; Xiechuan Weng; Fan Xu
Journal:  Oncol Rep       Date:  2021-09-09       Impact factor: 3.906

5.  RNA profiling of blood platelets noninvasively differentiates colorectal cancer from healthy donors and noncancerous intestinal diseases: a retrospective cohort study.

Authors:  Luming Xu; Xinbo Li; Xiangchun Li; Xingyue Wang; Qian Ma; Dan She; Xiaohuan Lu; Jiao Zhang; Qianqian Yang; Shijun Lei; Lin Wang; Zheng Wang
Journal:  Genome Med       Date:  2022-03-02       Impact factor: 11.117

6.  Elevated CEA and CA 19-9 Levels within the Normal Ranges Increase the Likelihood of CRC Recurrence in the Chinese Han Population.

Authors:  Lujia Wang; Guangkai Zhang; Jiafeng Shen; Yujiang Shen; Guojun Cai
Journal:  Appl Bionics Biomech       Date:  2022-09-22       Impact factor: 1.664

7.  Combination of serum lipids and cancer antigens as a novel marker for colon cancer diagnosis.

Authors:  Tong Li; Yinfen Qian; Hongling Li; Jiusheng Deng
Journal:  Lipids Health Dis       Date:  2018-11-20       Impact factor: 3.876

8.  Preoperative Predictors of Lymph Node Metastasis in Colon Cancer.

Authors:  Yansong Xu; Yi Chen; Chenyan Long; Huage Zhong; Fangfang Liang; Ling-Xu Huang; Chuanyi Wei; Shaolong Lu; Weizhong Tang
Journal:  Front Oncol       Date:  2021-05-31       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.